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Background: Efficient rule authoring tools are critical to allow clinical Knowledge Engineers (KEs), Software
Engineers (SEs), and Subject Matter Experts (SMEs) to convert medical knowledge into machine executable clinical
decision support rules. The goal of this analysis was to identify the critical success factors and challenges of a fully
functioning Rule Authoring Environment (RAE) in order to define requirements for a scalable, comprehensive tool
to manage enterprise level rules.
Methods: The authors evaluated RAEs in active use across Partners Healthcare, including enterprise wide,
ambulatory only, and system specific tools, with a focus on rule editors for reminder and medication rules. We
conducted meetings with users of these RAEs to discuss their general experience and perceived advantages and
limitations of these tools.
Results: While the overall rule authoring process is similar across the 10 separate RAEs, the system capabilities and
architecture vary widely. Most current RAEs limit the ability of the clinical decision support (CDS) interventions to be
standardized, sharable, interoperable, and extensible. No existing system meets all requirements defined by
knowledge management users.
Conclusions: A successful, scalable, integrated rule authoring environment will need to support a number of key
requirements and functions in the areas of knowledge representation, metadata, terminology, authoring
collaboration, user interface, integration with electronic health record (EHR) systems, testing, and reporting.
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Clinical decision support (CDS) is regarded as one of the
core functions essential to a modern Electronic Health
Record (EHR) [1,2], and the addition of CDS functional-
ity has been a critical step in the evolution of EHRs from
a primarily billing and documentation tool to a true pa-
tient care and population management tool. Certification
of an EHR under the U.S. Department of Health and
Human Services’ Meaningful Use criteria also requires* Correspondence: lzhou2@partners.org
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reproduction in any medium, provided the orsome degree of clinical decision support capability [1,2].
A good deal of effort has been devoted to analyzing the
effects of implementing new CDS interventions on
workflow, practitioner performance and patient out-
comes [3,4]. Much less effort to date has been invested
in examining the tools that enable the creation and
maintenance of the content used by CDS applications.
Rule authoring environment (RAE) refers to the suite
of tools that manage the end-to-end process of creating
specifications for rules, integrating with terminology,
and authoring, testing, publishing and reporting on
those rules. Comprehensive RAEs that touch each step
of that overall process are critical to create and maintain
decision support interventions and to make CDS rulestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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gional level, or even national level. Figure 1 shows major
rule authoring processes and corresponding knowledge
artifacts. Our aim is to examine existing technologies
and tools for designing, developing and maintaining
content for CDS rules, to study the major requirements
for RAEs, and to analyze the gaps to date in fulfilling
these requirements.
Background
The process of converting medical knowledge, which is
usually represented as text-based, ‘unstructured’ docu-
ments, such as clinical guidelines, to machine executable
CDS rules requires the collaboration of clinical Subject
Matter Experts (SMEs), Knowledge Engineers (KEs), and
Software Engineers (SEs). Shahar et al [5] defined that a
gradual conversion process includes four content-
representation formats: free text, semi-structured text,
semi-formal representation, and a formal representation
[6]. Researchers have proposed clinical guideline repre-
sentation languages and frameworks, such as Arden [7],
Asbru [8], EON [9], GEM [10,11], GLIF [12], GUIDE
[13], PRODIGY [14], PROforma [15], SAGE [16], and
OWL-based approaches [17] for modelling guidelines
and protocols in a computer interpretable and execut-
able format [5,18-21]. Even though, as reviewed by Peleg
et al [18], these computer-interpretable guideline models
have many components in common, they differ in the
underlying representation formalisms, decision models,
goal representation, use of scenarios, and structuredProcess Artifacts
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Figure 1 Major processes for rule authoring. This diagram
outlines six key processes for authoring CDS rules, key artifacts in
each process and some associated dependencies. It was developed
to assist in defining the requirements for a successful integrated
RAE.medical actions, and have different intended users and
applications. Software tools have been developed to as-
sist users in creating, editing, and interacting with these
guideline models. Examples include graphical tools, such
as AsbruView [22], Tallis [23], and Protégé [24], and
markup-based tools, such as DELT/A [25], GEM Cutter
[26], and Degel [27]. There were also other tools devel-
oped for capturing the knowledge required to create
guideline recommendations [28]. However, none of these
existing tools facilitate the entire process flow of trans-
forming free-text content into formal representations
and then further into executable rules designed for de-
ployment in a clinical environment. Therefore, standards
and mechanisms are still needed to allow these diverse
guideline models and tools to be shared between differ-
ent institutions and software platforms and to be used to
transform guidelines into encoded CDS artifacts that can
be embedded in real CDS systems [18].
This study focuses on rule authoring environments
(RAEs) used primarily to create and maintain rules for
common CDS interventions (such as alerts and remin-
ders) implemented in diverse EHR systems. RAEs in-
clude not only rule editors used to author rules, but also
other ancillary tools needed to span the steps of the rule
authoring process as described in Figure 1: creating
knowledge specifications, integrating with terminology,
authoring rules, testing rules, publishing rules and
reporting.
In early efforts at implementing CDS , it was often the
case that rules were hard-coded in the EHR system and
changes required a significant amount of software devel-
opment time. In some cases it might take weeks or
months before a revised rule was deployed to production
[29]. Recent efforts have been made to design rule edi-
tors that isolate knowledge base from execution. As
reported by Regier et al [29] at Partners Healthcare, the
introduction of a rule editor that interfaced with an ex-
ternal knowledge repository was found to greatly reduce
that turnaround time and give KEs more visibility of and
control over the content. Columbia University has cre-
ated a knowledge-acquisition tool to allow users un-
familiar with the Arden Syntax to create Medical Logic
Modules (MLMs) [30]. It attempts to divorce the entry
of decision logic from the underlying procedural code,
and is specific to the MLM knowledge representation.
Hulse and colleagues [31] developed an XML-based
knowledge authoring environment to compose order
sets and other structured clinical knowledge documents,
though not specifically CDS rules.
Goals of analysis
Partners HealthCare is an integrated health care system
in the Boston metropolitan area, founded by Brigham
and Women's Hospital and Massachusetts General
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specialty facilities, and other health-related entities. CDS
has long been a priority at Partners, and the institution
is regarded as one of the major sources of research and
development related to CDS [32]. The Knowledge Man-
agement (KM) team at Partners develops and maintains
a large variety of clinical knowledge content for Partners’
EHRs [33]. KEs on the KM team are usually clinicians,
including nurses, pharmacists, and physicians. The KEs
serve as a ‘bridge’ between SMEs and SEs, and normally
rely on RAEs to author and maintain CDS rules. Along
with the evolution of EHRs at Partners, RAEs have been
developed at different time periods for multiple purposes
and implemented on a variety of platforms. Some of
these tools are standalone, while others are embedded
within specific EHRs. Some are used to develop a cen-
tralized and shared knowledge base, for use in multiple
clinical settings and systems, while others are used to
build local or application-specific rules. There are no
shared patient data models, knowledge representation
formalisms, or computer-interpretable guideline models
that have been used to design and implement these
RAEs. Therefore, such non-interoperable environments
limit our efficiency in managing the collections of CDS
rules.
We conducted an assessment of the existing RAEs
used by Partners’ KM team to author content for CDS
rule-based interventions. In this paper, we will describe
the role of each tool and identify common and unique
features among the tools. We will analyze the advantages
and limitations of each tool. From our analysis, we will
compile the key requirements and challenges for RAEs.
This step is critical to help us identify possible solutions
to achieve our goal of developing common CDS rules as
well as centralized rule execution services across differ-
ent systems [34].
Methods
We identified currently active and supported CDS RAEs
used by Partners’ KM team with a focus on the following
two categories:
 Reminder Rule Editors: RAEs for managing clinical
reminder rules implementing chronic disease
management and general health maintenance
guidelines.
 Medication Rule Editors: RAEs for creating and
maintaining rules for medication management CDS,
including drug-drug, drug-food, drug-disease, drug-
lab, drug-pregnancy interaction, and other drug-
related rules.
Reminder rules extend to areas such as women’s health-
care, pediatric care, general adult care, or care for patientswho have specific diseases, such as osteoporosis, diabetes,
or hypertension. Examples of these types of reminders in-
clude overdue immunizations, recommended screening
tests such as mammograms, or recommendation for
Hemoglobin A1c ordering for diabetes. Examples of active
medication rules include warnings for Tylenol dosing in
liver disease, ACE inhibitor dosing when creatinine is ele-
vated, or safety warnings for antidepressants in pregnant
patients.
For each RAE, we identified the software platform on
which the RAE was developed, clinical setting in which
the rules are implemented (inpatient or ambulatory),
and clinical system in which the tool is embedded. We
also identified the scope of rules that are managed by
the system and estimated the number of active rules cur-
rently managed.
In order to identify strengths and weaknesses of the
individual systems, we conducted informal meetings
with KEs familiar with the tools to discuss their general
experience using these RAEs and the advantages and
limitations of these tools. For some technical features,
we also consulted SEs. This work was performed as part
of an internal review of information system applications
and therefore Institutional Review Board approval was
not required.
Results
Overview of the rule authoring environments
The RAEs at Partners included in this study are shown
in Table 1. They are used for different types of CDS rules
on different systems and platforms. The rules main-
tained in each tool are variably implemented for con-
sumption enterprise-wide, for the ambulatory EHR only,
or for specific hospital systems.
Diversity and unique features of the rule authoring
environments
In addition to a variety of platforms, scopes, and clinical
systems, the various editors also differ widely in design
and workflow process. The Reminder Editor, which has
been discussed in a previous paper [29], is a complex
editor designed to support authoring of diverse remin-
ders. Compared to the medication rules editors, which
are designed for more specific CDS interventions, the
Reminder Editor presents more decision points and
options for the KE to choose from, as shown in Figure 2.
It assists KEs to manage metadata and define rule logic
(e.g., risk group, overdue conditions, coded responses,
and message to clinicians receiving the reminder). It also
allows KEs to specify links to guidelines, supporting lit-
erature, and other reference content.
The Drug to Drug Interaction (DDI) editor is an ex-
ample of a tool that is designed for a specific workflow:
authoring medication interaction rules. A DDI rule usually
Table 1 Different RAEs and their characteristics*
RAE Setting Clinical System Scope Est. # of
Rulesξ
REMINDER RULE EDITORS
Reminder Editor (1st
generation)
Ambulatory Standalone Used by KEs for entering and editing reminder
rules
356
Reminder Editor (2nd
generation)
Ambulatory Embedded in an ambulatory EHR Used by KEs for entering and editing reminder
rules
356
Enterprise Rule Services
(3rd generation)
Ambulatory Standalone; service-oriented Used by KEs for entering and editing diverse
clinical decision support rules
120
MEDICATION RULE EDITORS
Drug-Drug Interaction
(DDI) Editor
Ambulatory and
inpatient
Standalone; web-based application Used by KEs for entering and editing DDI rules 2800
Renal Drug Dosing
(Nephros)
Ambulatory and
inpatient
Embedded in an inpatient CIS. CDS
rules are maintained in a specific
EHR, but are used at the enterprise
level by other systems
Used by KEs for entering and editing rules to
offer substitute drugs or adjust dose or frequency
list for a drug for renally impaired patients
(e.g., based on a particular Creatinine value)
352
Geriatric Drug Dosing
(Gerios)
Ambulatory and
inpatient
Embedded in an inpatient CIS. CDS
rules are maintained in a specific
EHR, but are used at the enterprise
level by other systems
Used by KEs for entering and editing rules to
offer substitute drugs or adjust dose or
frequency list for a drug for geriatric patients,
based on a particular age value
244
Neonate Pediatric Drug
Dosing
Inpatient Embedded in a medication
concept editor
Used by KEs for entering and editing rules to
offer substitute drugs or adjust dose or frequency
list for a drug for pediatric patients
1000
Food Drug Interaction Ambulatory and
inpatient
Embedded in a medication
concept editor
Used by KEs for entering and editing FDI rules 200
Duplicate Therapy Ambulatory and
inpatient
Standalone; web-based application Used by KEs for entering and editing rules to
detect potential drug duplications
190
Medication Rule Editor Ambulatory Embedded in an ambulatory EHR Maintains its own set of medication rules,
including drug-disease, drug-pregnancy, drug lab,
drug-group, group-group interactions
2300
*The platform of Medication Rule Editors is largely based on Cache and Visual Basic. The platform of Reminder Rule Editors varies. 1st generation is Microsoft
Access-based, 2nd generation is Cache based, and 3rd generation is Java-based.
ξMedication rule editors as of February 2009, Reminder rule editors as of February 2012.
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or a drug family), intervention level (e.g., dead stop, inter-
ruptive, or non-interruptive), message, conditions (e.g., if a
Potassium lab comes back > 3 within 24 hours, a DDI
associated with this condition will fire), and actions (e.g.,
order lab test when a particular DDI fires). It has a well-
defined set of input requirements and generates rules
without complicated branching logic, and thus has a rela-
tively fixed user interface, as shown in Figure 3.
While the inputs for entering a DDI rule are relatively
well defined, complexity is introduced in the tool by the
need to manage both individual drugs and drug families.
Since a DDI rule is often based on drug ingredient or
drug family, the editor needs to facilitate a complicated
process to manage and validate individual drugs that be-
long to the same family or have the same ingredient, but
have multiple trade names and dosage forms.
The Medication Rule Editor embedded in the Partners
ambulatory EHR maintains its own set of medication
rules, including drug-disease, drug-pregnancy, drug-lab,
drug-group, and group-group interactions. The editor
has a user interface that KEs find intuitive (Figure 4),similar to the Reminder Editor, but very different from
the other medication rule editors, such as the DDI
editor.
Major limitations of current systems
From our analysis of the various active RAEs in use across
Partners, several limitations of the current distributed sys-
tem became apparent, as described in the following.
Isolated
As noted in Table 1, most editors are embedded in ei-
ther inpatient/ambulatory EHR systems or terminology
editors and do not interface with a centralized know-
ledge repository. This can lead to overlaps or conflicts in
rules applicable to a given clinical scenario. For instance,
one set of rules may define inclusion criteria for diabetic
patients based on lab values, while another may define
inclusion criteria based on problem list entries. An inte-
grated editor and shared repository with robust report-
ing capabilities would facilitate the process of identifying
and resolving rules that conflict in this way. However, it
would not solve the problem of rule collision entirely.
(a) Reminder Maintenance
(b) Coded Responses 
(c) Actions
Figure 2 (See legend on next page.)
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Figure 2 Reminder Editor. The Reminder Editor allows users to add a new rule or view/edit existing rules. It has six tabs and this figure includes
screen shots of three of the six tabs of the Editor. 1) Reminder Maintenance (Figure 2a) records the metadata and a description of a rule. 2) The
Risk Group tab defines specific risk group primitives (such as age, allergy, and disease). 3) Overdue Condition evaluates the most recent data of a
test (e.g., Hemoglobin A1c) performed on the patient and determines if the test is due or overdue. 4) Coded Reponses (Figure 2b) are predefined
clinician recommendations or actions to be linked to the reminder. Each coded response may have a snooze period associated with it. Snooze
periods allow the clinician to defer the follow-up actions for a period of time. 5) Actions (Figure 2c) are commands that will automatically open
other system modules or places within LMR. This will allow the clinician to easily implement a coded response reminder recommendation for
orders, medications, radiology tests, and so on. 6) Physician Display defines the exact reminder message to be displayed in the patient’s
electronic medical records and also defines references (e.g., guidelines) for this reminder.
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drug dosing is maintained in the Renal Drug Dosing
(“Nephros”) editor, while age-based dosing is maintained
in the Geriatric Drug Dosing (“Gerios”) editor. If a medi-
cation concept is involved in both types of rules, the KE
needs to manually decide which rule to use based on in-
put from SMEs. In this case, it is the specific patient sce-
nario, geriatric patients who are also renally impaired,
that leads to conflict rather than inconsistent rule logic.
An integrated editor may assist KEs in identifying andFigure 3 DDI Editor (interaction between Warfarin and Sulfamethoxa
new DDI by entering a drug name (e.g., Warfarin) in the Medicine search fi
concepts coded by the First Data Bank Hierarchical Ingredient Code Seque
Warfarin. In the top right panel, the Editor provides some links to HIC_SEQ
Warfarin, where 395 is a system-generated DDI identifier and 2 is the level
intervention are 1- dead stop and 3 - non-interruptive. A text box appears
the DDI. To view the details of a DDI, a user can click on one of the DDI re
panel of the DDI Editor. On the left panel, the Editor displays the details of
drugs in Partners drug dictionary that are mapped to the HIC-SEQN, condit
using the user interface on the left panel.resolving potential collisions, but would not eliminate
occurrence of these scenarios.
Nonsharable
The rules maintained in each tool may be used at the en-
terprise level, but may be specific to ambulatory EHRs
only, or to specific hospitals or systems. Medication rules
that are created by the DDI editor, Nephros, and Gerios
are used at the enterprise level by other systems, but those
created by the Medication Rule editor are specific to thezole). On the right pane, a user can search for existing DDIs or add a
eld. The search returns existing DDI records organized by Warfarin
nce Number (HIC-SEQN). For example, H2084 is the HIC-SEQN for
N and Partners local drug dictionary. 395:2 represents a DDI record for
of the intervention (i.e., interruptive). The other two levels of
when the user hovers over 395:2 and shows more information about
cords or type the DDI identifier in the Record # box in the top left
a DDI, including message, locally defined category, intervention level,
ions and action. The user can modify existing DDI or define a new DDI
Figure 4 Medication Rule Editor in an ambulatory EHR. Rule editor used in ambulatory EHR to author drug-disease, drug-pregnancy, drug
lab, drug-group, group-group interactions.
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other practice environments, but are not available unless
duplicated manually. The “silo” nature of the current sys-
tem, with lack of enterprise-level availability of all rules, is
not just a result of having multiple authoring environ-
ments. It is also a result of having separate knowledge re-
positories and execution engines relying on different
knowledge representations. The resulting complexity leads
to inefficiency and duplication of effort.Nonstandardized
While physical sharing of the separate rule repositories
could theoretically be implemented in their current for-
mat, this could quickly become a complex task due to
the diversity of representation models and terminologies.
Most rules are expressed using local dictionaries and
using non-standardized knowledge representations. Bi-
directional transformation of rules between separate
environments and maintenance of inter-system concept
mapping is inefficient and untenable as a long-term
strategy. We are currently evaluating the feasibility of
using standard terminologies to encode data elements in
the rules (e.g., NDF-RT [35] and RxNorm [36] concepts
for medication rules); however, terminology mapping
and integration will still be a significant effort. An inte-
grated editor using a common rule representation
model, patient data model, and standard terminologies
would assist with this effort at the authoring level. Al-
though it would not eliminate the need for data mapping
at the implementation level, it would facilitate future de-
velopment of an enterprise-level rule engine or execu-
tion service.Nonextensible
The current RAEs are not well-structured to accommo-
date the future complexity of knowledge representation,because they were built to support the current state of
the rule content, which is primarily if-then logic and
some of the user interfaces were customized to match
Partners’ local terminology (see Figure 3). For instance,
genomic data and personalized medicine will likely be-
come clinically significant in the foreseeable future [37],
but could not be accommodated by any of the existing
specialized RAEs. Incorporating this new content, such
as drug-genome rules, would require modification of an
existing editor, or development of a new editor. Rule
logic is likely to get more complicated. For example, an
extensible RAE should be able to support rule chaining
or inferencing, which starts with some data and uses in-
ference rules to extract more data until a conclusion is
reached. Having a flexible, integrated authoring environ-
ment that is not content specific would require an
underlying extensible knowledge representation model
that is able to accommodate the present and future
knowledge. Such an environment should also be able to
provide a shared framework for terminology integration,
testing, reporting, lifecycle management, and other non-
content specific tasks.Disjointed
None of the RAEs have native support for the front-end
process of transforming guidelines into CDS rule specifica-
tions, or for soliciting the input of SMEs in design and val-
idation of these specifications. At Partners, a collaboration
platform is used to enable this process; however, the collab-
oration platform is not integrated with any of the RAEs,
thus once the rule specification is validated and approved
by the SMEs, the KEs must then manually transfer the rule
details to the applicable RAE. The KEs have the additional
overhead of maintaining the provenance and metadata that
associates the validated rule specification in the collabor-
ation platform to the implemented rule(s) in the RAE.
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Developing and maintaining separate RAEs requires the
efforts of specialized KEs and SEs, all of which are scarce
assets at most institutions. We were able to identify sev-
eral cases of workarounds and ‘hard-coding’ used to over-
come current editor and knowledge representation
deficiencies. It is easy to imagine a scenario in which the
primary developer or expert user of a specific tool leaves
the organization and the knowledge about the tool’s intri-
cacies is lost. It could be argued that having specialized
editors and KEs could make the system more efficient by
limiting the set of skills and training needed to use the sys-
tem. For example, KEs primarily responsible for encoding
drug-drug interaction rules may want a streamlined inter-
face that allows them to enter their data quickly, and may
not need to know about reminder rules or editors. Even in
this scenario, having a generic environment built around a
specialized editor will support maintenance of shared pro-
cesses such as terminology integration, testing, reporting,
and lifecycle management that apply to all rules without
sacrificing efficiency.
Discussion
In this paper, we have reviewed a set of clinical rule
authoring environments used by Knowledge Engineers
at Partners, which manage more than 7,000 CDS rules.
Currently, there is no single RAE that meets all require-
ments for all types of rules, and there are numerous
drawbacks of the current distributed system. We suspect
that many other large-scale institutions with homegrown
decision support systems went through a similar gradual
and piecemeal process of developing applications and
tools for CDS as the Partners system. Our findings are
of interest to set the requirement for better management
as institutions race headlong into CDS for a mature
EHR and Meaningful Use.
Critical success factors
Based on interviews with KEs and SEs and our analysis
of the rule authoring process, we can identify a number
of critical success factors and key functions that need to
be supported in order to establish a RAE in a robust,
scalable and extensible way. The functions described in
this section align with the processes in Figure 1 and the
requirements in the next section.
Formal knowledge representation and standards
The centralized, distributed rule service approach requires
rules represented and stored in a formal and standard rep-
resentation to be deployed to diverse EHRs. Current RAEs
use ad-hoc approaches to rule representation due to lack
of standards when they were built, combined with the de-
sire to address specific site needs or content areas quickly.
Usually, such legacy tools are localized in a healthcareorganization without connection with other information
systems and without interfaces to exchange information
between them. Changing this situation is a challenging
task that requires widely accepted open standards and
interface protocols, supported by robust implementation
tools.
Previous studies have proposed multiple knowledge
representation formalisms and models to represent clin-
ical practice guidelines [18-20], as reviewed in the back-
ground section. These models are used to represent
knowledge elements contained in guidelines, such as
plans, goals, actions, and decisions, as well as temporal
relationships (e.g., sequential, parallel, or cyclical) and
constraints between elements. In contrast, current RAE
representation models are typically only able to express
limited metadata with relatively simple triggering condi-
tions, coded responses, and actions. An ideal knowledge
model should be capable of expressing different types of
clinical knowledge, including complex relationships and
constraints. Future work is needed to validate more ex-
pressive guideline representation languages and frame-
works, particularly their effective integration with EHR
systems.
Metadata support
Extensive metadata support leveraging standard termin-
ologies is essential to assist KEs in the curation of large
sets of interdependent CDS artifacts. For example, there
might be as many as a hundred CDS artifacts for the
management of hyperlipidemia that take account of
multiple diagnosis combinations, multiple laboratory
results, as well as multiple medication combinations and
titration considerations. It is essential that the KE is able
to identify these as a relevant set and visualize them in a
manner that facilitates detection of gaps, inconsistencies
and/or errors.
Terminology integration
Medication terminology serves as a foundation for DDI
rules. Our local medication terminology, which is used
to encode medication orders in Partners’ EHRs, has a
relatively simple (non-hierarchical) structure. However,
each local medication concept is manually mapped to a
First Data Bank (FDB) [38] ingredient, enabling the iden-
tification of classes of medications that share the same
ingredients. KEs can look up and retrieve these propri-
etary medication concepts and classes using a RAE that
is integrated with the local medication terminology data-
base. The current DDI editor is rudimentary and requires
an experienced user to select and manage the appropriate
medication concepts and their classes. For reminder rules,
the RAEs are not fully integrated with terminology ser-
vices and KEs have to manually lookup and transcribe the
relevant terminology concepts and classes. If a well-
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management should ideally be separated from the rule de-
velopment; terminology services should provide a seam-
less integration of terminology into the rule authoring
process.
There are specific requirements and challenges for ter-
minology services to fully support an integrated RAE.
Currently at Partners, relevant terminology services are
maintained by different teams. One team covers services
for problems, diagnoses, and procedures. Another team
covers services for medications and allergies. Laboratory
test codes are provided by yet another team. In this sce-
nario, the terminology content, technical infrastructure,
and application development platforms are managed in-
dependently. In order to provide full support for an inte-
grated RAE, these various services need to be efficiently
integrated.
Another challenge worth mentioning is the manage-
ment of terminology classes (subsets), including problem
classes, which are used to group clinical findings that de-
fine a patient’s clinical state (e.g., if the patient has dia-
betes mellitus), and medication classes, which are used
to group medications that have the same therapeutic
effects, or the same set of ingredients. The problem
classes and the medication classes are created and mana-
ged using different editors. These editors allow users to
view and navigate standard terminologies and local
extensions created by Partners. While automated pro-
cesses have been developed to detect new candidates for
the problem classes, the maintenance of the subsets is
not fully automated. Some classes have constraints (e.g.,
a class for total hysterectomies that excludes partial hys-
terectomies as this class is used to suppress PAP smear
reminders) and SME review and approval is always
required before classes are released.
Collaboration support
The RAE should be able to support and facilitate the col-
laborative, iterative, and transparent processes amongst
clinical SMEs, KEs, and SEs [39]. However, today at Part-
ners, the collaboration environment is not integrated with
the RAEs, so documents and specifications vetted by
SMEs (e.g., free-text or intermediate representation of rule
logic) are stored, maintained and shared separately from
the RAE as Microsoft Word or Excel documents. Only a
few RAEs, including the Reminder editor, provide links to
the guideline, literature, or reference specification. Re-
cently, we have created structured and coded rule specifi-
cations using XML and XSLT technologies [31], but these
have not yet been incorporated into the existing RAEs. A
robust RAE should allow KEs to create free-text or inter-
mediate semi-structured representations of rule logic,
allow SMEs to comment on and adjust the logic, convert
them to a formal, executable representation, and thensubmit it to developers to integrate into the receiving ap-
plication for execution, all in an integrated and systematic
method.
The RAE should be able to support the efficient col-
laboration between medical terminologists and KEs.
When only local concepts are used in rules, KEs do not
need much assistance from terminology engineers (TEs).
As standard concepts, concept classes, and various map-
pings are incorporated, there is a greater need for sup-
port from TEs, SMEs, and Informaticians. It is often the
case that new CDS artifacts require the development of
new concept classes to support the CDS concern. KEs
should focus on the rule logic and consult with the ap-
propriate specialists as needed.
User interface
A sophisticated graphical user interface is critical for
user friendly RAEs. It should not only support more effi-
cient and effective user interaction, but also address the
individual end user (e.g., KE, SME, or SE) needs and
expectations. One critical success factor of the Reminder
editor is that it provides (primarily for KEs) a simple and
intuitive user interface that abstracts the complexity and
subtlety of the underlying clinical knowledge. Some
commercial or open-source products use traditional rule
logic representations and artifacts such as if-then rules
(with specific syntax), decision tables, and decision trees.
Recent efforts at Partners are attempting to centralize
rule development and maintenance, and to eventually
share these artifacts across different EHRs using a Java-
based commercial product for rule authoring and execu-
tion [40]. This commercial product employs object-
oriented modeling techniques to explicitly specify the
semantics and structures of clinical information needed
for the rules. However, it uses traditional CDS artifacts
such as if-then statements and decision tables, which are
easy to understand and manipulate by SEs, but not intui-
tive for clinically trained KEs who usually have limited
technical background and programming skills. An intui-
tive UI can streamline rule development for KEs through
the use of well-defined templates for managing metadata
and defining rule logic (e.g., risk group, overdue condi-
tions, physicians’ coded responses, and message) in a
way that separates the user interface from the underlying
knowledge representation needed for rule execution.
Integration with EHR systems
Although there are multiple existing guideline execution
engines that allow the enactment of clinical guidelines in
a semi-automatic or automatic fashion, none of them is
actually used in daily clinical practice. A major challenge
of the integration task is lack of an underlying common
EHR information model, which allows data defined in a
guideline model to be mapped to existing EHRs [21].
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Editors, Nephros, and Gerios as shown in Table 1) have
been integrated with EHR systems, they are part of the
specific systems and therefore not portable. A RAE should
adopt a formal information model that represents patient
data required in the rules. Regarding the system architec-
ture, the preferred RAE should be integrated with EHR
systems, for example, using a modular, service-oriented
architecture, so it will be more easily maintainable, port-
able, and scalable. It should be able to interact with EHR
systems, for example, via a set of interfaces and services
(e.g., the patient data service that retrieves the appropriate
patient data). It should also support testing and reporting
using real EHR data as described below. The RAE should
adopt standard open protocols and tools when they are
available.
Testing
A dedicated testing environment and integrated lifecycle
management process is essential to track rules from edit-
ing to testing to production. The Partners rules reviewed
in this study are published to a Quality Assurance (QA)
environment for testing, and then moved to Production,
often manually. This increases the chance that errors will
be introduced in the content with each transition. Further,
developing sufficient test patient data and concrete test
cases are time-consuming tasks, which require a signifi-
cant amount of lead time and resources. Given the rule
logic and parameters, it is technically feasible and desir-
able for a properly architected RAE testing system to gen-
erate all the test cases necessary to verify the rules.
Testing should be performed in controlled and itera-
tive manner. Testing should verify both the logic of the
rule itself and also functionality of the rule in the CDS
environment, such as redundancy and overlapping rule
logic, missing conditions and actions, conflict, and avail-
ability of data in EHR systems [41]. Initial testing may
focus on individual or small sets of rules and then be
expanded to the full set of rules. This helps to isolate
and resolve specific issues or unexpected results. Once
the rules are executing as expected, integration and user
acceptance testing can be initiated. Once the test process
is working consistently, the team should look for oppor-
tunities to automate or streamline the process so it can
be more easily repeated as the rules are refined.
Reporting
Reporting is critical when maintaining rule sets. Most
RAEs cannot currently generate reports. Reports for
medication rules are generated separately using another
user interface connected to the rule repository. The Re-
minder editor does not support reporting directly from
the tool itself, so reports are managed separately in an
Microsoft Access database. Robust reporting is neededin order to analyze existing rules and dependencies,
usage, and to audit performance and maintenance.
Requirements for a successful integrated RAE
We have defined the rule authoring workflow as shown
in Figure 1. Based on our analysis of the current existing
rule authoring environments at Partners and discussion
of critical success factors, we created following require-
ments for each of the processes in Figure 1.
Process 1: Create Knowledge Specifications
Includes reference content, knowledge specification,
use cases, workflow, business rules, metadata, etc.
✓ Store reference content and knowledge
specifications persistently in a central repository.
✓ Reuse and share existing content and avoid
redundancy.
✓ Support communication and collaboration across
different teams.
✓ Support metadata tagging to facilitate searching.
✓ Standard process for rule governance and lifecycle
management and versioning.
Process 2: Integrate with Terminology
Includes local terminology, commercial content,
standard terminology, and value sets.
✓ Ability to handle terminology updates in a timely
fashion.
✓ Ability to detect rule impact (be able to triage as no,
minor or major impact on rules).
✓ Ability to search, navigate and select terminologies
and concepts (e.g., terminology browser) directly from
user interface.
✓ Display concept names in the rules to make the
rules readable and understandable and store the
concept codes for the purpose of rule execution.
✓ Ability to navigate semantic relationships between
concepts.
✓ Ability to define, display and search value sets or
subsets of related terms.
Process 3: Author Rules
Includes local rules and enterprise rules.
✓ Central maintenance and coordination of content.
✓ Maintain and manage rules without dependence on
software development resources.
✓ Life cycle management and versioning.
✓ Ability to check to duplicate or overlapping rule logic.
✓ Ability to construct rules based on templates.
✓ Ability to construct rule artifacts such as decision
tables and rule flows.
✓ User-friendly features, such as form fields (e.g.,
check boxes, pick lists, and text boxes), drag and drop
functionality, intuitive advance searching, and help
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Process 4: Test Rules
✓ Allow rule logic to be validated independently from
the upstream or downstream services and applications.
✓ Eventually integrate with upstream and downstream
services and applications in order to perform
integration and user acceptance testing activities.
✓ Develop and maintain test patient data to support
the rule logic.
✓ Identify redundancy and overlapping rule logic.
✓ Identify missing conditions and actions.
✓ Identify conflicts with existing rules.
Process 5: Publish Rules
✓ Rules need to be made available for execution
within production clinical information systems.
✓ Rule specifications must be visible to users at
enterprise level.
✓ Executable representation must be available in
human readable format for review by SMEs and other
business people.
✓ Rules must be publishable to testing and runtime
environments without requiring manual re-entry.
Process 6: Reporting
✓ Analytical reports to identify conflicting rules,
incomplete rule coverage or rule redundancy.
✓ Comparison reports to identify when rules are
dependent on each other, so they can be tested and
managed together.
✓ Usage reports to specify which applications
consume the rules, so that future changes can be
communicated to the relevant teams.
✓ Audit reports to track rule changes, who made the
changes and why the changes were made.
✓ Execution reports to track frequency of individual
rule execution within the clinical systems and rates of
clinician acceptance or rejection of recommendations.Recent development
More recently, Partners has developed a multi-layered
knowledge representation framework to structure guide-
line recommendations for implementation in a variety of
CDS contexts [42]. This framework has adapted stan-
dards recommended by HL7 [43], Healthcare Informa-
tion Technology Standards Panel (HITSP) and elsewhere,
to create a formal information model that describes clin-
ical data required in the rules, and data are encoded using
standard terminologies (e.g., SNOMED [44], LOINC [45],
RxNorm [36]). An ongoing effort has been made to
centralize rule development and provide CDS services
across the enterprise.Study limitations
A major limitation of the current analysis is that the envir-
onments analyzed are limited to the Partners system. A
large number of institutions rely on vendor tools for deci-
sion support, which vary widely in design and features
[46]. Therefore, we cannot completely generalize our find-
ings to other institutions. We also limited our study to
RAEs in the areas of reminders and medications CDS.
This analysis does not include tools for other types of
CDS interventions, such as order sets, templates and info-
buttons. The tools in place at Partners all currently use
local terminologies and local, non-standard rule represen-
tations. We did not analyze in depth the effort or add-
itional tools which may be needed to facilitate translation
to and from standardized terminologies. There are cur-
rently gaps in standards for rule representations that need
to be more fully addressed in order to incorporate them
into an integrated RAE. Recommendations from these
efforts will likely inform requirements and specifications
for future RAEs.
Conclusions
Most existing RAEs at Partners limit the ability of the
CDS interventions to be standardized, sharable, inter-
operable, and extensible. We have identified key princi-
ples to consider in the design of an integrated RAE and
have discussed major requirements and challenges in the
areas of knowledge representation, metadata, termin-
ology, authoring collaboration, user interface, integration
with EHRs, testing, and reporting.
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